Cogent Biosciences
COGT
COGT
161 hedge funds and large institutions have $1.32B invested in Cogent Biosciences in 2024 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 54 increasing their positions, 47 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9% more funds holding
Funds holding: 148 → 161 (+13)
7% more call options, than puts
Call options by funds: $1.06M | Put options by funds: $993K
15.64% less ownership
Funds ownership: 126.96% → 111.31% (-16%)
Holders
161
Holding in Top 10
7
Calls
$1.06M
Puts
$993K
Top Buyers
| 1 | +$21.6M | |
| 2 | +$14.1M | |
| 3 | +$10.6M | |
| 4 |
BlackRock
New York
|
+$7.59M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.76M |
Top Sellers
| 1 | -$23.7M | |
| 2 | -$12.1M | |
| 3 | -$6.54M | |
| 4 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
-$6.19M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$5.49M |